LKB1 (STK11)
@stk11.bsky.social
www.frontiersin.org/journals/cel...
Review: "The Tumor Suppressor Kinase LKB1: Metabolic Nexus"
LKB1 loss is associated with multiple malignancies and causes metabolic reprograming to increase glycolysis and lactate production, elevate hexosamine biosynthesis and glutamine metabolism.
Review: "The Tumor Suppressor Kinase LKB1: Metabolic Nexus"
LKB1 loss is associated with multiple malignancies and causes metabolic reprograming to increase glycolysis and lactate production, elevate hexosamine biosynthesis and glutamine metabolism.
November 25, 2025 at 1:26 AM
www.frontiersin.org/journals/cel...
Review: "The Tumor Suppressor Kinase LKB1: Metabolic Nexus"
LKB1 loss is associated with multiple malignancies and causes metabolic reprograming to increase glycolysis and lactate production, elevate hexosamine biosynthesis and glutamine metabolism.
Review: "The Tumor Suppressor Kinase LKB1: Metabolic Nexus"
LKB1 loss is associated with multiple malignancies and causes metabolic reprograming to increase glycolysis and lactate production, elevate hexosamine biosynthesis and glutamine metabolism.
#LKB1 mutation (shown by green fluorescent protein) in lung cancer #metastasis. Beautiful image. Red = Actin. Cell nuclei in blue. 😍
Credit: National Cancer Institute / Winship Cancer Institute of Emory University / Science Photo Library @winshipatemory.bsky.social
#STK11
Credit: National Cancer Institute / Winship Cancer Institute of Emory University / Science Photo Library @winshipatemory.bsky.social
#STK11
March 12, 2025 at 6:56 PM
#LKB1 mutation (shown by green fluorescent protein) in lung cancer #metastasis. Beautiful image. Red = Actin. Cell nuclei in blue. 😍
Credit: National Cancer Institute / Winship Cancer Institute of Emory University / Science Photo Library @winshipatemory.bsky.social
#STK11
Credit: National Cancer Institute / Winship Cancer Institute of Emory University / Science Photo Library @winshipatemory.bsky.social
#STK11
pmc.ncbi.nlm.nih.gov/articles/PMC...
"Integration of Single-Cell and Bulk Transcriptomes to Identify a Poor Prognostic Tumor Subgroup to Predict the Prognosis of Patients with Early-stage Lung Adenocarcinoma"
"Integration of Single-Cell and Bulk Transcriptomes to Identify a Poor Prognostic Tumor Subgroup to Predict the Prognosis of Patients with Early-stage Lung Adenocarcinoma"
February 7, 2025 at 3:08 AM
pmc.ncbi.nlm.nih.gov/articles/PMC...
"Integration of Single-Cell and Bulk Transcriptomes to Identify a Poor Prognostic Tumor Subgroup to Predict the Prognosis of Patients with Early-stage Lung Adenocarcinoma"
"Integration of Single-Cell and Bulk Transcriptomes to Identify a Poor Prognostic Tumor Subgroup to Predict the Prognosis of Patients with Early-stage Lung Adenocarcinoma"